{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:16:54Z","timestamp":1779193014017,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Medical Microbiology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.ijmm.2014.11.002","type":"journal-article","created":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T16:12:30Z","timestamp":1415722350000},"page":"55-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["A human monoclonal antibody targeting the conserved staphylococcal antigen IsaA protects mice against Staphylococcus aureus bacteremia"],"prefix":"10.1016","volume":"305","author":[{"given":"Sanne","family":"van den Berg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrik P.J.","family":"Bonarius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kok P.M.","family":"van Kessel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goffe S.","family":"Elsinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neeltje","family":"Kooi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Westra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tjibbe","family":"Bosma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena M.","family":"van der Kooi-Pol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny G.A.M.","family":"Koedijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman","family":"Groen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Maarten","family":"van Dijl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girbe","family":"Buist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irma A.J.M.","family":"Bakker-Woudenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijmm.2014.11.002_bib0005","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1128\/IAI.00261-07","article-title":"Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax","volume":"75","author":"Albrecht","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0010","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.jp.7211496","article-title":"A blinded, randomized, multicenter study of an intravenous Staphylococcus aureus immune globulin","volume":"26","author":"Benjamin","year":"2006","journal-title":"J. Perinatol."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0015","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrmicro2200","article-title":"Waves of resistance: Staphylococcus aureus in the antibiotic era","volume":"7","author":"Chambers","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0020","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/501471","article-title":"Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage","volume":"193","author":"Clarke","year":"2006","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.ijmm.2014.11.002_bib0025","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1086\/499406","article-title":"The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs","volume":"42","author":"Cosgrove","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0030","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1086\/502522","article-title":"The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges","volume":"26","author":"Cosgrove","year":"2005","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0035","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jpeds.2007.04.060","article-title":"Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants","volume":"151","author":"DeJonge","year":"2007","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0040","doi-asserted-by":"crossref","first-page":"e53391","DOI":"10.1371\/journal.pone.0053391","article-title":"Characterization of the humoral immune response during Staphylococcus aureus bacteremia and global gene expression by Staphylococcus aureus in human blood","volume":"8","author":"den Reijer","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ijmm.2014.11.002_bib0045","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1002\/pmic.201000062","article-title":"Profiling the surfacome of Staphylococcus aureus","volume":"10","author":"Dreisbach","year":"2010","journal-title":"Proteomics"},{"key":"10.1016\/j.ijmm.2014.11.002_bib0050","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1128\/JB.186.4.1175-1181.2004","article-title":"Identification of genes controlled by the essential YycG\/YycF two-component system of Staphylococcus aureus","volume":"186","author":"Dubrac","year":"2004","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0055","doi-asserted-by":"crossref","first-page":"e00575","DOI":"10.1128\/mBio.00575-13","article-title":"Role of protein A in the evasion of host adaptive immune responses by Staphylococcus aureus","volume":"4","author":"Falugi","year":"2013","journal-title":"MBio"},{"key":"10.1016\/j.ijmm.2014.11.002_bib0060","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.coph.2009.07.008","article-title":"Anti-Staphylococcus aureus immunotherapy: current status and prospects","volume":"9","author":"Garc\u00eda-Lara","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0065","series-title":"Methods of Producing Stable B-lymphocytes","author":"Groen","year":"2010"},{"key":"10.1016\/j.ijmm.2014.11.002_bib0070","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1128\/IAI.74.5.2742-2750.2006","article-title":"Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine","volume":"74","author":"Kelly-Quintos","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nm.2071","article-title":"Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming","volume":"16","author":"Kwakkenbos","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0085","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1574-695X.2000.tb01517.x","article-title":"Human antibody response during sepsis against targets expressed by methicillin resistant Staphylococcus aureus","volume":"29","author":"Lorenz","year":"2000","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0080","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/AAC.01144-10","article-title":"Functional antibodies targeting IsaA of Staphylococcus aureus augment host immune response and open new perspectives for antibacterial therapy","volume":"55","author":"Lorenz","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0090","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199808203390806","article-title":"Staphylococcus aureus infections","volume":"339","author":"Lowy","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0095","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1128\/JCM.41.11.5113-5120.2003","article-title":"Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database","volume":"41","author":"McDougal","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0100","doi-asserted-by":"crossref","first-page":"926","DOI":"10.4161\/hv.27692","article-title":"Characterization of the biological anti-staphylococcal functionality of hUK-66 IgG1, a humanized monoclonal antibody as substantial component for an immunotherapeutic approach","volume":"10","author":"Oesterreich","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0105","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ijmm.2010.04.015","article-title":"Immunotherapeutic strategies to combat staphylococcal infections","volume":"300","author":"Ohlsen","year":"2010","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fcimb.2012.00036","article-title":"Characterization of the mechanism of protection mediated by CS-D7, a monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB)","volume":"2","author":"Pancari","year":"2012","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0115","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1128\/AAC.00570-07","article-title":"Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia","volume":"51","author":"Rupp","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00284-004-4381-9","article-title":"Subcellular location of the soluble lytic transglycosylase homologue in Staphylococcus aureus","volume":"50","author":"Sakata","year":"2005","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0135","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1128\/MMBR.00008-06","article-title":"Mapping the pathways to staphylococcal pathogenesis by comparative secretomics","volume":"70","author":"Sibbald","year":"2006","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0125","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1128\/JB.01452-09","article-title":"Synthetic effects of secG and secY2 mutations on exoproteome biogenesis in Staphylococcus aureus","volume":"192","author":"Sibbald","year":"2010","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0130","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1002\/pmic.201200144","article-title":"Partially overlapping substrate specificities of staphylococcal group A sortases","volume":"12","author":"Sibbald","year":"2012","journal-title":"Proteomics"},{"key":"10.1016\/j.ijmm.2014.11.002_bib0140","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nprot.2009.3","article-title":"Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen","volume":"4","author":"Smith","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0145","doi-asserted-by":"crossref","first-page":"7316","DOI":"10.1128\/JB.00734-07","article-title":"Characterization of IsaA and SceD, two putative lytic transglycosylases of Staphylococcus aureus","volume":"189","author":"Stapleton","year":"2007","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0150","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4049\/jimmunol.1203243","article-title":"Staphylococcus aureus formyl peptide receptor-like 1 inhibitor (FLIPr) and its homologue FLIPr-like are potent FcgammaR antagonists that inhibit IgG-mediated effector functions","volume":"191","author":"Stemerding","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0155","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"Tiller","year":"2008","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ijmm.2014.11.002_bib0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/jlb.61.2.173","article-title":"Dual effects of soluble CD14 on LPS priming of neutrophils","volume":"61","author":"Troelstra","year":"1997","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0165","doi-asserted-by":"crossref","first-page":"e59107","DOI":"10.1371\/journal.pone.0059107","article-title":"Distinctive cytokines as biomarkers predicting fatal outcome of severe Staphylococcus aureus bacteremia in mice","volume":"8","author":"van den Berg","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ijmm.2014.11.002_bib0170","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/jid.2012.347","article-title":"High anti-staphylococcal antibody titers in patients with epidermolysis bullosa relate to long-term colonization with alternating types of Staphylococcus aureus","volume":"133","author":"van der Kooi-Pol","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0175","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2217\/imt.11.84","article-title":"Immunotherapeutic approaches against Staphylococcus aureus","volume":"3","author":"Verkaik","year":"2011","journal-title":"Immunotherapy"},{"key":"10.1016\/j.ijmm.2014.11.002_bib0180","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1128\/AAC.00096-06","article-title":"Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia","volume":"50","author":"Weems","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2014.11.002_bib0185","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nature06890","article-title":"Rapid cloning of high-affinity human monoclonal antibodies against influenza virus","volume":"453","author":"Wrammert","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ijmm.2014.11.002_bib0190","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/pmic.200900313","article-title":"Proteomics uncovers extreme heterogeneity in the Staphylococcus aureus exoproteome due to genomic plasticity and variant gene regulation","volume":"10","author":"Ziebandt","year":"2010","journal-title":"Proteomics"}],"container-title":["International Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422114001507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422114001507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T03:48:02Z","timestamp":1566013682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1438422114001507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1438422114001507"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmm.2014.11.002","relation":{},"ISSN":["1438-4221"],"issn-type":[{"value":"1438-4221","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A human monoclonal antibody targeting the conserved staphylococcal antigen IsaA protects mice against Staphylococcus aureus bacteremia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmm.2014.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}